华纳药厂撤回盐酸阿罗洛尔片注册申请

Core Viewpoint - Hunan Warner Pharmaceutical Co., Ltd. has received a notice from the National Medical Products Administration regarding the termination of its drug registration application for Arolol Hydrochloride Tablets, which are primarily used for treating primary hypertension [1] Group 1 - The drug in question is classified as a Class 4 chemical drug with the acceptance number CYHS2401127 [1] - The company submitted the marketing authorization application in 2024 but has decided to withdraw it after careful consideration and alignment with its research and development strategy [1]